Vericel Corporation Logo

Email this page: News Release

Final Results from RESTORE-CLI Phase 2b Clinical Trial for Ixmyelocel-T in Treatment of Critical Limb Ischemia Published in the Peer-Reviewed Journal Molecular Therapy

For security reasons, registration is required before you can use this feature.
* Indicates required field